161.80CHF-0.49%Mkt Cap: 2.34B $P/E: —1d ago
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Busi…
Industry Peers
Medical Instruments & Suppliesvs Medical Instruments & Supplies
P/B
Cheaper
Div Yield
Avg
1M Perf
Avg
Indicators:|
Key Statistics
Company
Market Cap2.34B $
Enterprise Value2.23B $
Revenue (TTM)1.01B $
Gross Profit354.76M $
Net Income (TTM)-126.29M $
Revenue/Share79.54 USD
Last Price161.80 CHF
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees3.0K
CountryCH
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)21.38
PEG1.71
EV/EBITDA24.11
EV/Revenue2.21
P/S2.32
P/B1.76
EPS (TTM)-8.74
EPS (Forward)7.57
52W Range
110.6077% of range177.50
52W High177.50 CHF
52W Low110.60 CHF
Profitability
Gross Margin35.22%
Oper. Margin4.93%
EBITDA Margin9.16%
Profit Margin-12.54%
ROE-9.61%
ROA-6.52%
Growth
Revenue Growth-5.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF157.47M $
CapEx (TTM)40.29M $
FCF Margin12.86%
FCF Yield5.54%
Net Debt-106.19M $
Net Debt/EBITDA-1.15
Balance Sheet
Debt/Equity0.19
Current Ratio2.46
Quick Ratio1.69
Book Value/Sh91.87 CHF
Cash/Share24.84 CHF
Dividends
Fwd Div Rate3.000 CHF
Trail. Div Rate3.000 CHF
Div. Yield1.84%
5Y Avg Yield1.14%
Payout Ratio60.61%
Ex-Div DateApr 17, 2026
Pay DateApr 16, 2025
Analyst Consensus
Rating2.4 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)166.22 CHF
Upside (mean)+2.7%
Target Range138.00 CHF – 205.00 CHF
CHF138.00+2.7% to meanCHF205.00
# Analysts8
Ownership
Shares Out.12.66M
Float12.48M
Insiders0.43%
Institutions63.08%
Technical
SMA 50143.13 (+13.0%)
SMA 200138.86 (+16.5%)
Beta1.06
S&P 52W Chg20.05%
Avg Vol (30d)49.93K
Avg Vol (10d)49.03K
Technical Indicators
RSI (14)64.1
MACD4.1056
MACD Signal3.4946
MACD Hist.+0.6111
BB Upper165.46 CHF
BB Middle154.47 CHF
BB Lower143.49 CHF
BB Width14.23%
ATR (14)5.378 CHF
Vol Ratio (20d)0.63x